Programme - The British Society for Rheumatology
Programme - The British Society for Rheumatology
Programme - The British Society for Rheumatology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Programme</strong>:<br />
Thursday 14 April 2011<br />
<strong>Programme</strong><br />
Thu 14 April 2011<br />
“A good balance of<br />
presentations relevant<br />
to clinical practice whilst<br />
offering opportunities<br />
to expand scientific<br />
knowledge.”<br />
Delegate 2010
<strong>The</strong> future of patient<br />
choice in biologics<br />
Empress Suite, <strong>The</strong> Grand<br />
Thursday 14 April<br />
07.45–09.15<br />
This is an MSD symposium<br />
Please note breakfast will be served be<strong>for</strong>e the symposium<br />
Date of preparation: January 2011 01–12 SIM.11.GB.58111.J
44 <strong>Programme</strong> |Thursday 14 April 2011<br />
Thursday 14 April 2011<br />
Sessions | Clinical 1 | Clinical 2 | Research | Late breaking | BHPR | General<br />
07.15 – 07.45 Industry supported symposia catering<br />
07.45 – 09.15 Industry supported symposia<br />
07.45 Roche Chugai | Regency (Hilton Metropole)<br />
<strong>Rheumatology</strong>: are the planets aligning?<br />
Chair: Prof David G I Scott, Norfolk and Norwich University Hospital NHS Trust, Norwich<br />
Aim: To provide education on the changing NHS environment at national and local level and the<br />
impact on clinical practice and patient outcomes<br />
Outcome 1: Delegates will have gained a greater understanding of the political and clinical changes<br />
occurring within the NHS<br />
Outcome 2: Delegates will leave the session with a clear understanding of specific and realistic changes<br />
they can make to their <strong>Rheumatology</strong> Service to ensure it is optimally placed to meet the<br />
challenges of the evolving NHS<br />
Welcome and introduction | Prof David G I Scott, Norfolk and Norwich University Hospital NHS Trust, Norwich<br />
07:50 <strong>The</strong> value of big science | Prof Brian Cox, University of Manchester and CERN, Geneva<br />
08:05 Big Bang: the changing face of the NHS | Professor Paul Corrigan, Management Consultant, London<br />
08:20 Evolution: what will these changes mean at a local level? | Prof David Kerr, University of Ox<strong>for</strong>d, Ox<strong>for</strong>d<br />
08:35 Bringing the elements together: making it work <strong>for</strong> <strong>Rheumatology</strong> | Dr Andrew Östör, Addenbrooke’s<br />
Hospital, Cambridge<br />
08:55 Question and answer session<br />
09:10 Summary and close | Prof David G I Scott, Norfolk and Norwich University Hospital NHS Trust, Norwich<br />
07.45 MSD | Empress Suite (<strong>The</strong> Grand)<br />
<strong>The</strong> future of patient choice in biologics<br />
Aim: An in<strong>for</strong>mative discussion around patient choice and involvement and how this influences<br />
patient management.<br />
Outcome 1: Understanding how to offer patient choice when there is an increasing number of<br />
biologics available<br />
Outcome 2: Understanding the need <strong>for</strong> patient choice and benefits of current options<br />
Outcome 3: <strong>The</strong> White Paper and Patient Empowerment
<strong>Programme</strong> | Thursday 14 April 2011 45<br />
Sessions | Clinical 1 | Clinical 2 | Research | Late breaking | BHPR | General<br />
MSD | Empress Suite (<strong>The</strong> Grand)<br />
Moving towards joint decision-making: a recipe <strong>for</strong> success? | Dr Sam Moore, UCL, London<br />
Does the in<strong>for</strong>med patient exist: how can we work with them to achieve optimum outcomes?<br />
Dr Ruth Slack, West Suffolk Hospital, Bury St Edmonds<br />
<strong>The</strong> White Paper and patient empowerment: at the heart of the NHS | Ms Kate Gadsby, Royal Derby<br />
Hospital, Derby<br />
09.15 – 10.45 Exhibition | Tea and Coffee | Poster viewing<br />
10.45 – 12.45 Current therapeutic options <strong>for</strong> systemic sclerosis | Empress Suite (<strong>The</strong> Grand)<br />
Chairs: Prof Chris Denton, UCL Medical School, London and Dr Maya Buch, University of Leeds, Leeds<br />
Aim: To highlight the advances that have arisen in assessment and treatment of pulmonary<br />
complications of systemic sclerosis (scleroderma) and indicate how intense<br />
immunosuppression and targeted biological therapies have potential as disease modifying<br />
treatments in this disease<br />
Outcome 1: An understanding of goal-directed therapy <strong>for</strong> pulmonary arterial hypertension in scleroderma<br />
Outcome 2: An appreciation of outcome prediction and treatment options <strong>for</strong> interstitial lung<br />
fibrosis in scleroderma: when to treat and when to observe<br />
Outcome 3: Balance the benefit and toxicity of immunosuppressive treatments and potential of targeted<br />
therapy: lessons from inflammatory arthritis<br />
10.45 Current challenges in scleroderma | Prof Chris Denton, UCL Medical School, London<br />
11.00 Assessment and treatment of lung fibrosis in scleroderma | Dr Rachel Hoyles, Ox<strong>for</strong>d Radcliffe<br />
Hospitals, Ox<strong>for</strong>d<br />
11.30 Challenge of goal-directed therapy <strong>for</strong> pulmonary hypertension in scleroderma<br />
Dr Gerry Coghlan, Royal Free Hospital, London<br />
12.00 Immunosuppressive strategies in systemic sclerosis: enough already? | Prof Jaap van Laar,<br />
Newcastle University, Newcastle Upon Tyne<br />
12.30 Panel discussion<br />
10.45 – 12.45 Advances in early inflammatory arthritis | Ox<strong>for</strong>d (Hilton Metropole)<br />
Chairs: Prof Michael Ehrenstein, UCL, London and Prof Costantino Pitzalis, Barts and the London, London<br />
Aim: To learn about early rheumatoid arthritis, from pathogenesis to novel therapies<br />
Outcome 1: Understand the issues relating to establishing and running an early arthritis clinic<br />
Outcome 2: Gain knowledge on the environmental and genetic risk factors of RA<br />
Outcome 3: Gain insights on how pathobiology may contribute to diverse disease outcome and response<br />
to therapy and be in<strong>for</strong>med on the latest thoughts about how best to treat early RA<br />
10.45 Genetic and environmental risk factors in early rheumatoid arthritis | Prof Lars Klareskog,<br />
Karolinska University Hospital in Solna, Stockholm, Sweden
46 <strong>Programme</strong> |Thursday 14 April 2011<br />
Sessions | Clinical 1 | Clinical 2 | Research | Late breaking | BHPR | General<br />
Advances in early inflammatory arthritis | Ox<strong>for</strong>d (Hilton Metropole)<br />
11.10 How to establish an early arthritis clinic: pitfalls and opportunities to improve patient care<br />
Dr Karim Raza, University of Birmingham, Birmingham<br />
11.40 Can pathobiology in<strong>for</strong>m disease outcome and response to therapy? | Prof Costantino Pitzalis,<br />
Barts and the London, London<br />
12.05 Pre rheumatoid arthritis and early rheumatoid arthritis: what does it mean? | Prof Paul Tak,<br />
Academic Medical Center/University of Amsterdam, Amsterdam, <strong>The</strong> Netherlands<br />
12.30 Panel discussion<br />
10.45 – 12.45 ARMA late breaking session | ARS (interactive audience response system) | Regency (Hilton Metropole)<br />
Chair: Mr Roy Lilley, NHS Commentator<br />
Everything you wanted to know about commissioning; but were afraid to ask<br />
Want to know more about Commissioning - but afraid to ask? Well this is the session <strong>for</strong> you.<br />
ARMA will bring together a panel of experts who will talk you through what is involved, the pitfalls and the<br />
successes and link you up with others that are trying to understand how rheumatology can work in an integrated<br />
way with primary care to provide the care that patients and you want<br />
Panel: MrAsh Soni, PEC Chair, NHS Lambeth | Dr Alan Nye, Associate Medical Director NHS Direct,<br />
Associate Medical Director Pennine Care NHS Foundation Trust, Director Pennine MSK Partnership Ltd,<br />
Principal in General Practice | Dr Chris Deighton, Consultant Rheumatologist | Dr Alan Hakim, Consultant<br />
Physician and Rheumatologist, Director of Strategy and Business Improvement<br />
10.45 – 12.45 BHPR and Arthritis Research UK presentation of prizes | Albert (<strong>The</strong> Grand)<br />
Chair: Ms Lindsey Hawley, President BHPR<br />
10.45 Introduction from the panel | Ms Lindsey Hawley, President BHPR, Mr Keir Windsor, Education Manager Arthritis<br />
Research UK and Mrs Alisa Bosworth, Chief Executive National Rheumatoid Arthritis <strong>Society</strong><br />
10.50 BHPR Student/recently qualified health professional prize winner<br />
Miss Serena Naidoo University of Brighton, Brighton<br />
I could cry, the amount of shoes I can't get into<br />
11.05 BHPR Clinical prize winner<br />
Dr Lisa Roberts Arthritis Research UK senior lecturer in physiotherapy, Southampton<br />
Case study 'Jim'<br />
11. 20 Chris Moran poster prize winner<br />
<strong>The</strong> Chris Moran poster prize is awarded to the author of one audit and one research poster at the conference<br />
11.25 BHPR/Arthritis Research UK silver medal research prize<br />
Mr Gordon Hendry University of Western Sydney, Sydney, Australia (Presented by Dr Deborah Turner,<br />
Glasgow Caledonian University, Glasgow)<br />
Clinical and ultrasound (US) examinations of foot disease in juvenile idiopathic arthritis (JIA): interobserver<br />
agreement between a paediatric rheumatologist, podiatrist and a sonographer
<strong>Programme</strong> | Thursday 14 April 2011 47<br />
Sessions | Clinical 1 | Clinical 2 | Research | Late breaking | BHPR | General<br />
BHPR and Arthritis Research UK presentation of prizes | Albert (<strong>The</strong> Grand)<br />
11.40 Arthritis Research UK/PRCA podiatry silver medal prize<br />
Dr Vicki Cameron-Fiddes<br />
A study to investigate the effectiveness of a commonly prescribed off-the-shelf foot orthosis on foot health related<br />
quality of life (QOL) in patients with early diagnosed rheumatoid arthritis (RA)<br />
12.00 NRAS patients in focus 2011<br />
Mrs Kanta Kumar, Nurse Researcher, Immunity and Infection <strong>Rheumatology</strong> Department, University of<br />
Birmingham, Birmingham<br />
<strong>The</strong> development of an Asian language helpline <strong>for</strong> South Asian patients with rheumatological conditions<br />
in Birmingham<br />
12.45 – 14.15 Applying psychological interventions to the management of inflammatory arthritis and<br />
musculoskeletal pain | Dukes (Hilton Metropole)<br />
Chairs: Dr Claire Goodchild, Institute of Psychiatry, London and Dr Emma Dures, Bristol Royal Infirmary, Bristol<br />
Spaces are limited to 60 <strong>for</strong> this interactive workshop. Registration <strong>for</strong> this session will be open from<br />
09.15 on Thursday 14 April 2011 in the registration area<br />
Aim: To increase knowledge of cognitive behavioural therapy (CBT) and motivational interviewing<br />
(MI) as useful tools in symptom management<br />
Outcome 1: Delegates will have been introduced to CBT and MI and introduce basic skills<br />
Outcome 2: Delegates will have learned how to recognise and address the impact of negative thoughts<br />
Outcome 3: Delegates will have been learned about the different applications of therapy<br />
12.45 Applying cognitive behavioural therapy <strong>for</strong> insomnia <strong>for</strong> patients with chronic pain<br />
Dr Nicole Tang and Dr Claire Goodchild, Institute of Psychiatry, London<br />
12.55 Applying cognitive behavioural approaches in a group <strong>for</strong> the self management of RA fatigue<br />
Dr Nicholas Ambler, <strong>The</strong> Pain Management Centre, Bristol and Dr Emma Dures, Bristol Royal Infirmary, Bristol<br />
13.05 Using MI to identify and combat negative styles of thinking: exploring resistance | Dr Marianne Morris.<br />
University of the West of England, Bristol and Ms Elizabeth Hale, Russells Hall Hospital, Birmingham<br />
13.15 Delegates will <strong>for</strong>m three groups and each group will rotate <strong>for</strong> 20 minutes discussion on the<br />
above applications.<br />
12.45 – 14.15 Exhibition | Lunch
48 <strong>Programme</strong> |Thursday 14 April 2011<br />
Sessions | Clinical 1 | Clinical 2 | Research | Late breaking | BHPR | General<br />
12.45 – 14.00 BSR AGM | Empress Suite (<strong>The</strong> Grand)<br />
You are invited to the BSR Annual General Meeting<br />
Come along and receive progress reports from the President,<br />
the Journal Editor, the Heberden Librarian and other Honorary Officers<br />
about the business of the <strong>Society</strong> which will also include:<br />
• 2010 Annual Accounts and subscriptions <strong>for</strong> 2012<br />
• Changes to the <strong>Society</strong>’s Articles<br />
• BSR Elections Results<br />
<strong>The</strong> meeting will also include a thank you and farewell session <strong>for</strong> departing officers.<br />
Your participation is valued so we hope to see you all there. Lunch is also provided.<br />
14.15 – 15.45 Vasculitis: current issues | Ox<strong>for</strong>d (Hilton Metropole)<br />
Chair: Dr Chetan Mukhytar, Norfolk and Norwich University Hospital, Norwich<br />
Aim: To provide practicing clinicians with a useful update on current clinical management and<br />
how new research may drive the management of the vasculitides in new directions<br />
Outcome 1: To better understand the aetiopathogenesis of the vasculitides<br />
Outcome 2: To better understand the investigation and diagnosis of PMR/GCA<br />
Outcome 3: To better understand the appropriate use of novel therapies in vasculitis<br />
14.15 Pathogenesis of vasculitis | Prof Cees Kallenberg, University Medical Center Groningen,<br />
Groningen, <strong>The</strong> Netherlands<br />
14.45 What is the evidence <strong>for</strong> novel immunosuppressants/B cell depletion in vasculitis?<br />
Dr Rachel Jones, University of Cambridge, Cambridge<br />
15.05 Diagnosis and assessment of large vessel vasculitis | Dr Raashid Luqmani, University of Ox<strong>for</strong>d,<br />
Nuffield Orthopaedic Hospital, Ox<strong>for</strong>d<br />
15.25 Treatment of PMR/GCA | Prof Bhaskar Dasgupta, Southend Hospital University Foundation<br />
NHS Trust, Westcliffe on Sea
<strong>Programme</strong> | Thursday 14 April 2011 49<br />
Sessions | Clinical 1 | Clinical 2 | Research | Late breaking | BHPR | General<br />
14.15 – 15.45 <strong>The</strong> era of biologics <strong>for</strong> children and young people with rheumatological disease | Albert (<strong>The</strong> Grand)<br />
Chairs: Dr Michael Beres<strong>for</strong>d, Royal Liverpool Children’s Hospital, Liverpool and<br />
Dr Jacqui Clinch, Royal National Hospital <strong>for</strong> Rheumatic Diseases, Bath<br />
Aim: To provide a state-of-the-art overview of the latest translational and therapeutic advances <strong>for</strong><br />
children and young people with rheumatic disease<br />
Outcome 1: Provide in<strong>for</strong>mation on the latest advances in evidence base and clinical use of biologics in<br />
children and young people<br />
Outcome 2: Understand the importance of translational research in determining the mechanism of disease<br />
and treatment response in children<br />
Outcome 3: Identify the significant challenges and importance of specific expertise in treating children and<br />
adolescents, and requirements <strong>for</strong> dealing appropriately with their transition and transfer needs<br />
14.15 <strong>The</strong>rapeutic advances in juvenile idiopathic arthritis | Dr Athimalaipet Ramanan, Bristol Royal<br />
Hospital <strong>for</strong> Children and Royal National Hospital <strong>for</strong> Rheumatic Diseases, Bath<br />
14.35 Understanding the mechanism of disease and response to therapy in childhood arthritis<br />
Prof Lucy Wedderburn, Institute of Child Health, University College London and Great Ormond<br />
Street Hospital, London<br />
14.55 <strong>The</strong> young adult with juvenile idiopathic arthritis and biologics | Prof Helen Foster,<br />
<strong>The</strong> Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne<br />
15.15 Genetics and biologic use in inflammatory disease | Dr Paul Brogan, Great Ormond Street Hospital, London<br />
14.15 – 15.45 Clinical musculoskeletal research in the UK (Arthritis Research UK and BSR joint session)<br />
Empress suite (<strong>The</strong> Grand)<br />
Chairs: Dr Clive Kelly, Queen Elizabeth Hospital, Gateshead and Prof David Scott, UCL, London<br />
Aim: To discuss with delegates: the need <strong>for</strong> developing strategic networks<br />
and funding <strong>for</strong> clinical musculoskeletal research in the UK<br />
Outcome 1: To review all current activity ranging from experimental medicine to studies of health care<br />
delivery, illustrating contribution of different funders and other stakeholders such as NICE<br />
Outcome 2: To present the structure, design and functioning of the new proposed network <strong>for</strong> arthritis and<br />
related research in the UK<br />
Outcome 3: A detailed presentation of how to participate, what are the logistic issues and how to solve<br />
them and to provide panel answers to questions from the floor<br />
14.15 Current and future activity in rheumatology trials | Prof Alan Silman, Arthritis Research UK<br />
14.35 Building a UK clinical research network in rheumatology | Prof David L Scott, UCL, London<br />
14.55 What are the practical issues? | Prof Deborah Symmons, University of Manchester, Manchester<br />
15.35 Panel discussion
50 <strong>Programme</strong> |Thursday 14 April 2011<br />
Sessions | Clinical 1 | Clinical 2 | Research | Late breaking | BHPR | General<br />
14.15 – 15.45 Patient and public involvement in musculoskeletal research | Regency (Hilton Metropole)<br />
Chairs: Ms Sue Gurden, Gwent NHS Trust, Newport and Ms Catherine Ball, Imperial College, London<br />
Aim: To provide participants with an overview of patient and public involvement (PPI) in<br />
musculoskeletal research<br />
Outcome 1: Delegates will be able to identify the role of PPI in musculoskeletal research and<br />
clinical practice<br />
Outcome 2: Examples will be provided of PPI activity (national and international)<br />
Outcome 3: Delegates will enhance their understanding of the implementation of PPI in research<br />
and clinical practice<br />
14.15 <strong>The</strong> national agenda | Dr Sarah Buckland, INVOLVE, Leeds<br />
14.30 Public priorities <strong>for</strong> joint pain research | Dr Claire Jinks, Arthritis Research UK Primary Care Centre, Keele<br />
14.55 A decade of patient involvement in OMERACT: what difference has it made?<br />
Prof John Kirwan, Bristol Royal Infirmary, Bristol and Mr Maarten de Wit, OMERACT<br />
15.20 Patient and public involvement in the work of Cochrane Musculoskeletal Group<br />
Dr Tamara Rader, University of Ottawa, Ottawa, Canada<br />
15.45 – 16.15 Exhibition | Tea and Coffee<br />
16.15 – 17.15 Heberden Round | Ox<strong>for</strong>d ( Hilton Metropole)<br />
Chair: Prof David L Scott, BSR President<br />
Aspects of infection | Prof Hill Gaston, Professor of <strong>Rheumatology</strong>, Addenbrooke’s Hospital, Cambridge